✦ LIBER ✦

Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine

✍ Scribed by C.Myra L Sloper; Richard J Powell; Harminder S Dua

Book ID: 117329565
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 235 KB
Volume: 106
Category: Article
ISSN: 0161-6420
DOI: 10.1016/s0161-6420(99)90156-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab in the treatment of refractor

Infliximab in the treatment of refractory posterior uveitis

✍ Annie Joseph; Dev Raj; Harminder S Dua; Pauline T Powell; Peter C Lanyon; Richar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Topical tacrolimus (FK 506) is effective

Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum

✍ Dagmar Richter-Hintz; Hans-Christian Schuppe; Bernhard Homey; Percy Lehmann; Tho 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Tacrolimus and cyclosporine efficacy in

Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation on behalf of the European Multicentre Tacrolimus (FK506) Renal Study Group

✍ I.A. Hauser; H.-N. Neumayer 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 405 KB

Everolimus for the treatment of uveitis

Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study

✍ Arnd Heiligenhaus, Beatrix Zurek-Imhoff, Martin Roesel, Maren Hennig, Daniela Ra 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

Occurrence of gammopathies and lymphopro

Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression

✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i

Tacrolimus hydrate (FK506): therapeutic

Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis

✍ Nobuo Wakata; Toyokazu Saito; Sachiko Tanaka; Toshihiko Hirano; Kitaro Oka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 110 KB